Value of CT-Scan & Oral Gastrografin in the Management of Post Operative

Status Completed

Clinical Trial Summary

Small bowel obstructions are responsible for 2 to 5% of emergency hospital admissions and 20% of all emergency surgical procedures. In 60 to 80% of cases, acute small bowel obstructions are the consequence of intraperitoneal postoperative adhesions. They constitute an extremely frequent pathology, leading to a high rate of hospital admissions and money expense.

Management of small bowel obstruction is based on 2 options: either a surgical approach where all patients are operating on, or a conservative treatment in which surgery is proposed in case of failure of medical treatment. The surgical approach leads to operate on an excessive rate of patients while the medical approach increases the risk of increased small bowel resection, morbidity rate or hospitalization duration.

In order to improve the management of small bowel obstruction, it seems necessary to better distinguish patients that need an emergency surgical procedure from patients in which medical treatment will be useful. Many studies have been performed to investigate the value of imaging in the management of small bowel obstruction, using abdominal X-ray, oral gastrografin administration or CT-Scan.

The aim of this study is to analyse the effect of a systematic performance of imaging investigation on the management of patients presenting with a postoperative small bowel obstruction.

All patients suffering from a postoperative small bowel obstruction will be included in this study. They will be randomised in 2 groups. In group S, patients will have CT-Scan and oral water administration while in group SG, Patients will have CT-Scan and oral gastrografin administration The major end point of this study is to analyse whether imaging examination can reduce the need for a surgical approach or the rate of small bowel resection and to determine its influence on fasting time or hospitalization duration

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00389116
Study type	Interventional
Source	University Hospital, Rouen
Contact
Status	Completed
Phase	Phase 4
Start date	November 2006
Completion date	August 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02065661` - Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)	N/A
Completed	`NCT05517057` - Radiologic Score and Failure of Conservative Management of Adhesive Small Bowel Obstruction
Not yet recruiting	`NCT05864378` - POCUS for Small Bowel Obstruction in the ED: a Retrospective Study
Terminated	`NCT03573921` - Gastrografin for Treating Small Bowel Obstruction in Children	Phase 2/Phase 3
Recruiting	`NCT05315765` - Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
Not yet recruiting	`NCT01934283` - Intrabdominal Pressure in Small Bowel Obstruction as a Possible Predictor for the Need of Operation	N/A
Not yet recruiting	`NCT04001985` - Nasogastric Tube Clamping Trial vs. Immediate Removal	N/A
Enrolling by invitation	`NCT05878015` - A Study of Intravenous Acetaminophen for Small Bowel Obstruction	Phase 4
Recruiting	`NCT03139149` - Comparison of Early Operative Treatment and 48 h Conservative Treatment in Small Bowel Obstruction	N/A
Active, not recruiting	`NCT06101719` - Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction
Not yet recruiting	`NCT05843097` - SnapSBO - Small Bowel Obstruction Snapshot Audit
Completed	`NCT05662384` - Small Bowel Obstruction. A Prospective Multicener Study
Completed	`NCT04929275` - Enhanced Recovery Programs and Small Bowel Obstruction	N/A
Not yet recruiting	`NCT06140173` - Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction	N/A
Completed	`NCT01082627` - Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction	Phase 4
Completed	`NCT03461744` - Diagnostic Scoring for Small Bowel Obstruction
Completed	`NCT02190981` - Point of Care Ultrasound for Suspected Small Bowel Obstruction in the Emergency Department
Completed	`NCT01524081` - Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures	Phase 3
Recruiting	`NCT06065150` - Early Surgery Versus 3 Days Non-surgical Management in Acute Small Bowel Obstruction (SURGI-BOW)	N/A
Completed	`NCT03386136` - Therapeutic Oxygen for Gastrointestinal Atony (TOGA)	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms